1. Levy JA, Ibrahim AB, Shirai T, et al. Dietary fat affects immune
response, production of antiviral factors, and immune complex disease in NZP/NZW mice.
Proc Natl Acad Sci 1982;79:1974–8. 2. Jacobsson I, Lindgarde F, Manthorpe R, et al. Correlation of fatty
acid composition of adipose tissue lipids and serum phosphatidylcholine and serum
concentrations of micronutrients with disease duration in rheumatoid arthritis. Ann Rheum
Dis 1990;49:901–5. 3. Lucas CP, Power L. Dietary fat aggravates active rheumatoid arthritis.
Clin Res 1981;29:754A [abstract]. 4. Skoldstam L. Fasting and vegan diet in rheumatoid arthritis. Scand
J Rheumatol 1987;15:219–21. 5. Nenonen M, Helve T, Hanninen O. Effects of uncooked vegan
food—“living food”—on rheumatoid arthritis, a three month controlled
and randomised study. Am J Clin Nutr 1992;56:762 [abstract #48]. 6. Warmbrand M. How Thousands of My Arthritis Patients Regained Their
Health. New York: Arco Publishing, 1974. 7. Panush RS, Carter RL, Katz P, et al. Diet therapy for rheumatoid
arthritis. Arthrit Rheum 1983;26:462–71. 8. KjeldsenKragh J, Haugen M, Borchgrevink CF, et al. Controlled
trial of fasting and oneyear vegetarian diet in rheumatoid arthritis. Lancet
1991;338:899–902. 9. Linos A, Kaklamani VG, Koukmantaki Y, et al. Dietary factors in
relation to rheumatoid arthritis: a role for olive oil and cooked vegetables. Am J Clin
Nutr 1999;70:1077–82. 10. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive
oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects.
Arthritis Rheum 1990;33:810–20. 11. Hafström I, Ringertz B, Gyllenhammar H, et al. Effects of
fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene
biosynthesis in patients with rheumatoid arthritis. Arthritis Rheum
1988;31:585–92. 12. Skoldstam L, Magnusson KE. Fasting, intestinal permeability, and
rheumatoid arthritis. Rheum Dis Clin North Am 1991;17:363–71 [review]. 13. KjeldsenKragh J, Haugen M, Borchgrevink CF, et al. Controlled
trial of fasting and oneyear vegetarian diet in rheumatoid arthritis. Lancet
1991;338:899–902. 14. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Forre O. Vegetarian diet
for patients with rheumatoid arthritis-status: two years after introduction of the diet.
Clin Rheumatol 1994;13:475–82. 15. KjeldsenKragh J, Haugen M, Borchgrevink CF, et al. Controlled
trial of fasting and oneyear vegetarian diet in rheumatoid arthritis. Lancet
1991;338:899–902. 16. Seignalet J. Diet, fasting, and rheumatoid arthritis. Lancet
1992;339:68–9 [letter]. 17. Abuzakouk M, O’Farrelly C. Diet, fasting, and rheumatoid
arthritis. Lancet 1992;339:68 [letter]. 18. Panayi GS. Diet, fasting, and rheumatoid arthritis. Lancet
1992;339:69 [letter]. 19. Cordain L, Toohey L, Smith MJ, Hickey MS. Modulation of immune
function by dietary lectins in rheumatoid arthritis. Br J Nutr
2000;83(3):207–17. 20. Zeller M. Rheumatoid arthritis—food allergy as a factor.
Ann Allerg 1949;7:200–5,239. 21. Darlington LG, Ramsey NW, Mansfield JR. Placebocontrolled,
blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet
1986;i:236–8. 22. Beri D, Malaviya AN, Shandilya R, Singh RR. Effect of dietary
restrictions on disease activity in rheumatoid arthritis. Ann Rheum Dis
1988;47:69–72. 23. Panush RS. Possible role of food sensitivity in arthritis. Ann
Allerg 1988;61(part 2):31–5. 24. Taylor MR. Food allergy as an etiological factor in arthropathies: a
survey. J Internat Acad Prev Med 1983;8:28–38 [review]. 25. O’Farrelly C, Price R, McGillivray AJ, Fernandes L. IgA
rheumatoid factor and IgG dietary protein antibodies are associated in rheumatoid arthritis.
Immunol Invest 1989;18(6):753–64. 26. Darlington LG, Ramsey NW. Diets for rheumatoid arthritis.
Lancet 1991;338:1209 [letter]. 27. Heliövaara M, Aho K, Knekt P, et al. Coffee consumption,
rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis
2000;59:631–5. 28. Kay DR, Webel RB, Drisinger TE, et al. Aerobic exercise improves
performance in arthritis patients. Clin Res 1985;33:919A [abstract]. 29. Harkcom TM, Lampman RM, Banwell BF, Castor CW. Therapeutic value of
graded aerobic exercise training in rheumatoid arthritis. Arthrit Rheum
1985;28:32–8. 30. Westby MD, Wade JP, Rangno KK, Berkowitz J. A randomized controlled
trial to evaluate the effectiveness of an exercise program in women with rheumatoid arthritis
taking low dose prednisone. J Rheumatol 2000;27:1674–80. 31. Ozturk HS, Cimen MY, Cimen OB, et al. Oxidant/antioxidant status of
plasma samples from patients with rheumatoid arthritis. Rheumatol Int
1999;19:35–7. 32. Fairburn K, Grootveld M, Ward RJ, et al. Alpha-tocopherol, lipids and
lipoproteins in knee-joint synovial fluid and serum from patients with inflammatory joint
disease. Clin Sci 1992;83:657–64. 33. Scherak O, Kolarz G. Vitamin E and rheumatoid arthritis. Arthrit
Rheum 1991;34:1205–6 [letter]. 34. Wittenborg A, Petersen G, Lorkowski G, Brabant T. Effectiveness of
vitamin E in comparison with diclofenac sodium in treatment of patients with chronic
polyarthritis. Z Rheumatol 1998;57:215–21 [in German]. 35. Kolarz G, Scherak O, El Shohoumi M, Blankenhorn G. High dose vitamin
E for chronic arthritis. Akt Rheumatol 1990;15:233–7 [in German]. 36. Edmonds SE, Winyard PG, Guo R, et al. Putative analgesic activity of
repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a
prospective placebo controlled double-blind trial. Ann Rheum Dis
1997;56:649–55. 37. Miehle W. Vitamin E in active arthroses and chronic polyarthritis.
What is the value of alpha-tocopherol in therapy? Fortschr Med
1997;115:39–42. 38. Pullman-Mooar S, Laposata M, Lem D, et al. Alteration of the cellular
fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic
acid. Arthritis Rheum 1990;33:1526–33. 39. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis
with gammalinolenic acid. Ann Intern Med 1993;119:867–73. 40. Zurier RB, Rossetti RG, Jacobson EW, et al. Gamma-linolenic acid
treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis
Rheum 1996;39:1808–17. 41. Leventahn LJ, Boyce EG, Zuerier RB. Treatment of rheumatoid arthritis
with black currant seed oil. Br J Rheumatol 1994;33:847–52. 42. Brzeski M, Madhok R, Capell HA. Evening primrose oil in patients with
rheumatoid arthritis and sideeffects of nonsteroidal antiinflammatory drugs.
Brit J Rheumatol 1991;30:370–2. 43. Jantti J, Seppala E, Vapaatalo H, Isomaki H. Evening primrose oil and
olive oil in treatment of rheumatoid arthritis. Clin Rheumatol
1989;8:238–44. 44. Belch JJ, Ansell D, Madhok R, et al. Effects of altering dietary
essential fatty acids on requirements for nonsteroidal antiinflammatory drugs in
patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum
Dis 1988;47:96–104. 45. Kremer JM, Jubiz W, Michalek A, et al. Fishoil fatty acid
supplementation in active rheumatoid arthritis. Ann Int Med
1987;106(4):497–503. 46. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive
oil supplementation in patients with rheumatoid arthritis. Arthrit Rheum
1990;33(6):810–20. 47. Geusens P, Wouters C, Nijs J, et al. Longterm effect of
omega3 fatty acid supplementation in active rheumatoid arthritis. Arthrit Rheum
1994;37:824–9. 48. Van der Tempel H, Tulleken JE, Limburg PC, et al. Effects of fish oil
supplementation in rheumatoid arthritis. Ann Rheum Dis 1990;49:76–80. 49. Cleland LG, French JK, Betts WH, et al. Clinical and biochemical
effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol
1988;15(10):1471–5. 50. Kremer JM, Lawrence DA, Petrillow GF, et al. Effects of
highdose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory
drugs. Arthritis Rheum 1995;38:1107–14. 51. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment
with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte
leukotriene generation and neutrophil function. N Engl J Med
1985;312(19):1217–24. 52. Nordstrom DC, Honkanen VE, Nasu Y, et al. Alpha-linolenic acid in the
treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study:
flaxseed vs. safflower seed. Rheumatol Int 1995;14:231–4. 53. Siemandi H. The effect of cis-9- cetyl myristoleate (CMO) and
adjunctive therapy on arthritis and auto-immune disease: a randomized trial. Townsend
Letter for Doctors and Patients. 1997;Aug/Sept:58–63. 54. American Medical Association. Dimethyl sulfoxide. Controversy and
Current Status—1981. JAMA 1982;248:1369–71. 55. Jimenez RAH, Willkens RF. Dimethyl sulfoxide: A perspective of its
use in rheumatic diseases. J Lab Clin Med 1982;100:489–500. 56. Jacob SW, Wood DC. Dimethyl sulfoxide (DMSO). Toxicology,
pharmacology, and clinical experience. Am J Surg 1967;114:414–26. 57. Barton-Wright EC, Elliott WA. The pantothenic acid metabolism of
rheumatoid arthritis. Lancet 1963;ii:862–3. 58. General Practitioner Research Group. Calcium pantothenate in
arthritic conditions. Practitioner 1980;224:208–11. 59. Gibson RG, Gibson SLM, Conway V, Chappell D. Perna canaliculus in the
treatment of arthritis. Practitioner 1980;224:955–660. 60. Audeval B, Bouchacourt P. Etude controle en double aveugle contra
placebo de l’extrait de moule Perna canaliculus dans las gonarthrose. Gazette
Medicale 1986;38:111–6. 61. Huskisson EC, Scott J, Bryans R. Seatone is ineffective in rheumatoid
arthritis. BMJ 1981;282:1358–9. 62. Caughey DE, Grigor RR, Caughey EB, et al. Perna canaliculus in the
treatment of rheumatoid arthritis. Eur J Rheumatol Inflamm 1983;6:197–200. 63. Larkin JG, Capell HA, Sturrock RD. Seatone in rheumatoid arthritis: a
six-month placebo controlled study. Ann Rheum Dis 1985;44:199–201. 64. Highton TC, McArthur AW. Pilot study on the effect of New Zealand
green mussel on rheumatoid arthritis. N Z Med J 1975;81:261–2. 65. Gibson SLM, Gibson RG. The treatment of arthritis with a lipid
extract of Perna canaliculus: a randomized trial. Comp Ther Med
1998;6:122–6. 66. Brooks PM. Side effects from Seatone. Med J Aust 1980;2:158
[letter]. 67. Aaseth J, Munthe E, Forre O, Steinnes E. Trace elements in serum and
urine of patients with rheumatoid arthritis. Scand J Rheumatol
1978;7:237–40. 68. Simkin PA. Oral zinc sulphate in rheumatoid arthritis.
Lancet 1976;ii:539–42. 69. Peretz A, Neve J, Jeghers O, Pelen F. Zinc distribution in blood
components, inflammatory status, and clinical indexes of disease activity during zinc
supplementation in inflammatory rheumatic diseases. Am J Clin Nutr
1993;57:690–4. 70. Job C, Menkes CJ, de Gery A, et al. Zinc sulphate in the treatment of
rheumatoid arthritis. Arthrit Rheum 1980;23:1408. 71. Simkin PA. Treatment of rheumatoid arthritis with oral zinc sulfate.
Agents Actions 1981;8(suppl):587–96. 72. Tarp U, Overvad K, Hansen JC, Thorling EB. Low selenium level in
severe rheumatoid arthritis. Scand J Rheumatol 1985;14:97–101. 73. Aaseth J, Munthe E, Forre O, Steinnes E. Trace elements in serum and
urine of patients with rheumatoid arthritis. Scand J Rheumatol
1978;7:237–40. 74. Peretz A, Neve J, Duchateau J, Famaey JP. Adjuvant treatment of
recent onset rheumatoid arthritis by selenium supplementation: preliminary observations.
Br J Rheumatol 1992;31:281–2 [letter]. 75. Tarp U, Overvad K, Thorling EB, et al. Selenium treatment in
rheumatoid arthritis. Scand J Rheumatol 1985;14:364–8. 76. DiSilvestro RA, Marten J, Skehan M. Effects of copper supplementation
on ceruloplasmin and copperzinc superoxide dismutase in freeliving rheumatoid
arthritis patients. J Am Coll Nutr 1992;11:177–80. 77. Jones AA, DiSilvestro RA, Coleman M, Wagner TL. Copper
supplementation of adult men: effects on blood copper enzyme activities and indicators of
cardiovascular disease risk. Metabolism 1997;46:1380–3. 78. Medical News. Copper boosts activity of anti-inflammatory drugs.
JAMA 1974;229:1268–9. 79. Sorenson JRJ. Copper complexes—a unique class of
antiarthritic drugs. Progress Med Chem 1978;15:211–60 [review]. 80. Walker WR, Keats DM. An investigation of the therapeutic value of the
‘copper bracelet’—dermal assimilation of copper in arthritic/rheumatoid
conditions. Agents Actions 1976;6:454–9. 81. Blake DR, Lunec J. Copper, iron, free radicals and arthritis.
Brit J Rheumatol 1985;24:123–7 [editorial]. 82. Newnham RE. Arthritis or skeletal fluorosis and boron. Int Clin
Nutr Rev 1991;11:68–70 [letter]. 83. Balagot RC, Ehrenpreis S, Kubota K, et al. Analgesia in mice and
humans by D-phenylalanine: Relation to inhibition of enkephalin degradation and enkephalin
levels. Adv Pain Res Ther 1983;5:289–93. 84. Hartung EF, Steinbroker O. Gastric acidity in chronic arthritis.
Ann Intern Med 1935;9:252. 85. Cohen A, Goldman J. Bromelain therapy in rheumatoid arthritis.
Pennsylvania Med J 1964;67:27–30. 86. Park EH, Kahng JH. Suppressive effects of propolis in rat adjuvant
arthritis. Arch Pharm Res 1999;22:554–8. 87. Siro B, Szelekovszky S, Lakatos B, et al. Local treatment of
rheumatic diseases with propolis compounds. Orv Hetil 1996;137:1365–70 [in
Hungarian]. 88. Etzel R. Special extract of Boswellia serrata in the
treatment of rheumatoid arthritis. Phytomed 1996;3:91–4 [review]. 89. Singh GB, Singh S, Bani S. New phytotherapeutic agent for the
treatment of arthritis and allied disorders with novel mode of action. 4th International
Congress on Phytotherapy, Munich, Germany, Sep 10–3, 1992. 90. Chopra A, Lavin P, Patwardhan B, Chitre D. Randomized double blind
trial of an Ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J
Rheumatol 2000;27:1365–72. 91. Sander O, Herborn G, Rau R. Is H15 (resin extract of Boswellia
serrata, “incense”) a useful supplement to established drug therapy of chronic
polyarthritis? Results of a double-blind pilot study. Z Rheumatol 1998 ;57:11–6
[in German]. 92. Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with
topical capsaicin: A double-blind trial. Clin Ther 1991;13:383–95. 93. Bone K. The story of devil’s claw: Is it an herbal
antirheumatic? Nutrition and Healing 1998;October:3,4,8 [review]. 94. Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis
with a herbomineral formulation: A double-blind, placebo-controlled, cross-over study. J
Ethnopharmacol 1991;33:91–5. 95. Deodhar SD, Sethi R, Srimal RC. Preliminary studies on antirheumatic
activity of curcumin (diferuloyl methane). Ind J Med Res 1980;71:632–4. 96. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in
rheumatism and musculoskeletal disorders. Med Hypoth 1992;39:342–8. 97. Chopra A, Lavin P, Patwardhan B, Chitre D. Randomized double blind
trial of an Ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J
Rheumatol 2000;27:1365–72. 98. Randall C, Meethan K, Randall H, Dobbs F. Nettle sting of Urtica
dioica for joint pain—an exploratory study of this complementary therapy. Compl
Ther Med 1999;7:126–31. 99. Mills SY, Jacoby RK, Chacksfield M, Willoughby M. Effect of a
proprietary herbal medicine on the relief of chronic arthritic pain: A double-blind study.
Br J Rheum 1996;35:874–8. 100. Upton R, Petrone C, eds. Willow bark (Salix spp.)
monograph. Santa Cruz, CA: American Herbal Pharmacopoeia, 1999. 101. Blumenthal M, Busse WR, Goldberg A, et al., eds. The Complete
German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American
Botanical Council and Boston: Integrative Medicine Communications, 1998, 430–1. 102. Langer JG, Gupta OP, Atal CK. Clinical trials on Picrorhiza
kurroa. Ind J Pharmacol 1981;13:98–103 [review]. 103. Zeylstra H. Filipendila ulmaria. Br J Phytotherapy
1998;5:8–12. 104. Tao X, Cush JJ, Garret M, Lipsky PE. A phase I study of ethyl
acetate extract of the Chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid
arthritis. J Rheumatol 2001;28:2160–7. 105. Tao X, Younger J, Fan FZ, et al. Benefit of an extract of
Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: A double-blind,
placebo-controlled study. Arthritis Rheum 2002;46:1735–43. 106. Dhondt W, Willaeys T, Verbruggen LA, et al. Pain threshold in
patients with rheumatoid arthritis and effect on manual oscillations. Scand J
Rheumatol 1999;28:88–93. |